11 results
424B3
LMNL
Liminal BioSciences Inc.
12 Nov 20
Prospectus supplement
5:21pm
, and increase patient access to lower-cost generic and biosimilar drugs. On March 10, 2020, the Trump administration sent “principles” for drug … pricing to Congress, calling for legislation that would, among other things, cap Medicare Part D beneficiary out-of-pocket pharmacy expenses, provide
6-K
EX-99.6
LMNL
Liminal BioSciences Inc.
12 Nov 20
Liminal BioSciences Reports Third Quarter Financial Results
5:07pm
generic and biosimilar drugs. On March 10, 2020, the Trump administration sent “principles” for drug pricing to Congress, calling for legislation that would
424B3
LMNL
Liminal BioSciences Inc.
30 Sep 20
Prospectus supplement
5:14pm
, and increase patient access to lower-cost generic and biosimilar drugs. On March 10, 2020, the Trump administration sent “principles” for drug pricing … , and increased governmental control of drug pricing.
In March 2010, the Physician Payments Sunshine Act, enacted as part of the Patient Protection
F-1/A
moagp25t
14 Sep 20
Registration statement (foreign) (amended)
4:56pm
6-K
EX-99.2
63h7q lfwgf85x
17 Aug 20
Current report (foreign)
4:14pm
6-K
EX-99.1
vn3slqm8rkicc90astt
17 Aug 20
Current report (foreign)
4:14pm
F-1
4g05j nmi3ygv
13 Aug 20
Registration statement (foreign)
5:25pm
6-K
EX-99.2
rdc3uqw3 tl4ylgmwwvr
10 Aug 20
Liminal Biosciences Reports Financial Results for Q2-2020
5:11pm
20-F
oon0t1o nyzjn4qv
20 Mar 20
Annual report (foreign)
5:12pm
- Prev
- 1
- Next